UNSPSC 51284031: Doxycycline phosphate

This classification denotes a tetracycline antibiotic with the molecular formula C22H24N2O8.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QG2V1M96HM. European Medicines Agency schedules doxycycline phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01833MIG. Most nations, for tariff and trade purposes, schedule doxycycline phosphate under HS 29413000 and SITC 54133. As of Q4 2014, DOXYCYCLINE PHOSPHATE remains US FDA's Preferred Term for this commodity.

Doxycycline phosphate bears US NLM identifiers UMLS ID CL436807 and NCI Concept Code C102526. SMILES: C[C@H]1C2CCCC(C2C(=O)C3=C([C@]4([C@@H]([C@H]([C@H]13)O)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O.OP(=O)(O)O.

UNSPSC 51284031 Doxycycline phosphate is a Commodity code that shows minimal relevance to state and local procurement activity in the recent opportunities block. The code nominally covers a specific antibiotic pharmaceutical product, yet the recent solicitations posted under this code address naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency responders, and multi-source generic pharmaceuticals and OTC products—none of which are doxycycline or closely related to it. The mismatch between the code's nominal scope and the actual work being solicited suggests either a tagging error in the source data or that doxycycline itself sees limited recent state and local procurement activity worth tracking.

The issuing bodies across these opportunities span county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and cooperative purchasing alliances serving multiple states (Minnesota Multistate Cooperative Purchasing Alliance, which includes Oregon participants). Representative recent solicitations include Seminole County's IFB60459723LAS for naloxone and drug deactivation systems with a response deadline of July 26, 2023 (note: this date appears to predate the posting date and may reflect a data error); the City of Tampa's IFB 26P00145 for medical and first aid supplies with a response deadline of March 13, 2026; and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals with a proposal deadline of March 26, 2026. Geographic activity appears concentrated in the Southeast and Upper Midwest, with visible procurement from Florida, Texas, and Minnesota, though the cooperative purchasing vehicle extends to Oregon. If doxycycline is a targeted product line, monitor cooperative purchasing vehicles and state health department RFPs rather than this code's recent activity.